Pirmenol Hydrochloride

盐酸吡美诺

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NamePirmenol Hydrochloride

Drug Alias NamePimavarPimenolCI-845

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium channel protein type VIII alpha subunit blockersSodium channel protein type II alpha subunit blockersSodium channel protein type IV alpha subunit blockers +[8]

TargetsSodium channel protein type II alpha subunitSodium channel protein type VIII alpha subunitSodium channel protein type IX alpha subunit +[8]

Therapy Area/IndicationsArrhythmias, Cardiac

Global Approved IndicationsArrhythmias, Cardiac

Approved Indications in ChinaN/A

Original Approved Country/TerritoryJapan

Original Approved Date1994/01/01

Country/TerritoryJapan

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc Sumitomo Dainippon

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsArrhythmias, Cardiac

Inactive IndicationsN/A

Other Information

ATC CodeC01BA